上海新陽(300236.SZ):將以4500萬元受讓芯刻微剩餘的30%股權
格隆匯10月12日丨上海新陽(300236.SZ)公佈,2021年10月12日,公司與上海超成科技有限公司(“超成科技”)簽署了《股權轉讓協議》。公司將支付4500萬元受讓由超成科技轉讓的上海芯刻微材料技術有限責任公司(“芯刻微”)剩餘的30%股權。芯刻微目前系公司的控股子公司,主要進行ArF浸沒式光刻膠項目的研發。轉讓完成後,上海新陽持有芯刻微100%股權,超成科技將不再持有芯刻微股權。
芯刻微目前系公司的控股子公司,僅進行ArF浸沒式光刻膠的研發工作,2020年公司為芯刻微引入戰略投資者超成科技,在超成科技作為芯刻微大股東的期間,芯刻微完成了項目的前期研發、團隊建設、實驗室的工程建設工作,並避免公司或有的風險損失,保證了濕法光刻膠項目的正常開展。上海超成履行了作為股東應有的職責和義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.